Stock A109960 AP HEALTHCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials AP Healthcare Inc.

Equities

A109960

KR7109960005

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
599 KRW -0.66% Intraday chart for AP Healthcare Inc. -2.28% -23.11%
Mar. 13 Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Aprogen Healthcare & Games Inc. announced that it has received KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 131,222 148,182 132,471 125,151 66,950 51,548
Enterprise Value (EV) 1 94,832 103,571 101,306 69,004 -14,380 55,057
P/E ratio 10.1 x -21.8 x 12 x 47.2 x -11.9 x 24 x
Yield - - - - - -
Capitalization / Revenue 6.76 x 6.77 x 12.8 x 14.9 x 6.98 x 3.22 x
EV / Revenue 4.88 x 4.73 x 9.82 x 8.2 x -1.5 x 3.44 x
EV / EBITDA 84.6 x 2,340 x 4,671 x -31.8 x 1.22 x -2.69 x
EV / FCF -6.36 x -117 x -1.98 x 5.77 x -0.46 x 13.1 x
FCF Yield -15.7% -0.86% -50.6% 17.3% -216% 7.65%
Price to Book 0.6 x 0.7 x 0.57 x 0.56 x 0.34 x 0.31 x
Nbr of stocks (in thousands) 35,707 35,707 35,707 35,707 35,707 66,172
Reference price 2 3,675 4,150 3,710 3,505 1,875 779.0
Announcement Date 3/20/19 3/13/20 3/15/21 3/14/22 3/17/23 3/13/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 19,417 21,901 10,319 8,416 9,598 16,007
EBITDA 1 1,120 44.27 21.69 -2,167 -11,810 -20,454
EBIT 1 607 -659.2 -375.2 -2,579 -12,099 -21,004
Operating Margin 3.13% -3.01% -3.64% -30.65% -126.05% -131.22%
Earnings before Tax (EBT) 1 8,778 -6,918 8,225 2,647 -5,261 5,578
Net income 1 8,741 -6,754 11,084 2,650 -5,607 4,304
Net margin 45.02% -30.84% 107.42% 31.49% -58.41% 26.89%
EPS 2 363.0 -190.0 310.0 74.21 -157.0 32.42
Free Cash Flow 1 -14,904 -887.9 -51,244 11,958 31,062 4,214
FCF margin -76.76% -4.05% -496.61% 142.08% 323.63% 26.32%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - 451.26% - 97.9%
Dividend per Share - - - - - -
Announcement Date 3/20/19 3/13/20 3/15/21 3/14/22 3/17/23 3/13/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 3,509
Net Cash position 1 36,389 44,611 31,165 56,147 81,330 -
Leverage (Debt/EBITDA) - - - - - -0.1716 x
Free Cash Flow 1 -14,904 -888 -51,244 11,958 31,062 4,214
ROE (net income / shareholders' equity) 5.18% -3.21% 5.01% 1.17% -2.66% 1.69%
ROA (Net income/ Total Assets) 0.2% -0.18% -0.1% -0.7% -3.44% -4.88%
Assets 1 4,374,702 3,741,940 -10,761,439 -381,060 163,171 -88,197
Book Value Per Share 2 6,090 5,895 6,493 6,235 5,570 2,518
Cash Flow per Share 2 281.0 491.0 888.0 323.0 443.0 80.80
Capex 1 42.1 96.3 30 5.72 - 25
Capex / Sales 0.22% 0.44% 0.29% 0.07% - 0.16%
Announcement Date 3/20/19 3/13/20 3/15/21 3/14/22 3/17/23 3/13/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
AP HEALTHCARE INC. Stock AP Healthcare Inc.
-23.11% 49.66M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A109960 Stock
  4. Financials AP Healthcare Inc.